It’s More Than Earnings Holding Back Walgreens
Walgreens Boots Alliance slid on Thursday after the company reported disappointing fiscal third-quarter financial results and guidance.
All Work
Chris Lange
Will Bed Bath & Beyond Ever Recover From COVID-19?
Bed Bath & Beyond shares were crushed on Thursday after the company reported disappointing first-quarter results.
Why Dollar Stores Have More Upside Than Walmart and Costco
Big names like Walmart and Costco certainly will ride out the pandemic. Surprisingly, dollar stores appear to have a fighting chance too, and they could even offer more upside than the retail behemoths.
NanoViricides COVID-19 Treatment Offers Alternative to Antibodies
NanoViricides made another stride in the fight against COVID-19, and investors have to be happy about it.
Why Pfizer’s Stock Could Rise 60% or More
Pfizer is among the current frontrunners for a COVID-19 vaccine, so why is its stock down 13% year to date? And why does one independent research firm say this stock could run much higher?
Why This Analyst Sees Big Upside in COVID-19 Immunotherapy Study
After Corvus Pharmaceuticals announced that it would initiate an early-stage immunotherapy study in patients with COVID-19, Wedush sees this stock running much higher.
Biogen Could Still Have Massive Upside From Its Alzheimer’s Drug
Biogen may be on track to be one of the first companies with a meaningful treatment for Alzheimer’s disease, and this could have huge implications for the stock.
5 Hot IPOs That Should Come Out Ahead of the 2020 Election
Here are some of the biggest and most eagerly awaited companies that are looking to come public ahead of the 2020 election.
How Much Elective Surgeries Have Really Dropped Off During the COVID-19 Pandemic
Many hospitals shut down elective surgeries and other activities to brace for the impact of COVID-19. However, analysis on these shutdowns is yielding some interesting insight.
Why This Apple Analyst Is So Cautious Despite Rising iPhone 12 Visibility
The iPhone 12 launch is just around the corner, and more investors are throwing their money at Apple anticipating a win. However, one analyst is taking a very cautious approach to the upcoming launch.
Why Investors Are Excited About This New Immunotherapy COVID-19 Study
Corvus Pharmaceuticals watched the COVID-19 stock bump play out in Tuesday’s session as this company joins the ever-growing list of coronavirus stocks.
Operation Warp Speed Against COVID-19 Ramps Up With Novavax and Regeneron
Novavax and Regeneron Pharmaceuticals each made solid progress on Tuesday after each company received a sizable capital injection from the U.S. government’s Operation Warp Speed program.
5 Speculative COVID-19 Stocks That Could Still Surge
24/7 Wall Street has picked out a few of the best and brightest coronavirus stocks that could still see a big push as 2020 continues.
5 SPAC and Blank Check Stocks That Have Exploded Higher in 2020
24/7 Wall St. has put together a list of special purpose acquisition company stocks and blank check stocks that could win big this year, and these aren’t just the ones involved in sports betting.
Bed Bath & Beyond, Levi Strauss, Walgreens and More Earnings Coming This Week
24/7 Wall St. offers a preview of what to expect from some of the most anticipated quarterly results due this week.
5 FDA COVID-19 Decisions in July Could Make or Break Stocks
Here is a look of a few of the biggest clinical trial and FDA updates to watch for in July 2020.
Lemonade Enters the Market With a Bang
Insurance company Lemonade entered the market with a bang on Thursday.
How E-Commerce Is Saving Francesca’s and Could Save Even More Retailers
Francesca’s shares more than doubled on Thursday after the company announced the development of its first mobile e-commerce application.
Why Akero’s Liver (NASH) Treatment Could Take This Stock Much Higher
Akero Therapeutics has been public for only about a year now, and despite shares surging over 30% to an all-time high in Wednesday’s session, analysts think this stock can go much higher.
Have Analysts Become Too Positive About Apple’s iPhone 12?
A lot of Apple stock’s recent momentum has been due to the excitement around the upcoming iPhone 12 and 5G. Is there a wave of new purchases of smartphones, personal computers and tablets coming…